Reporter Virus Particles

Non-Replicative Virus Particles for Safe Neutralization Assays

Integral Molecular® Reporter Virus Particles (RVPs) are for scientists working to develop vaccines, antibodies, and other countermeasures against the world’s deadliest and most challenging viruses.

Schematics of a pseudoviral particle and a pseudoinfective virus-like particle. Both have viral surface proteins and a lipid bilayer. Inside the pseudoviral particle, a heterologous core surrounds a reporter. In the virus-like particle, a capsid surrounds the reporter RNA.

RVPs are non-replicative virus-like particles with surface proteins from a diverse range of viruses. They are a safe, ready-to-use substitute for live virus, ideal for infectivity and neutralization assays.

Built on a foundation of 20+ years’ virology experience, RVPs meet high quality standards, and they’re easy to use with standard instruments.

Product Offerings:The Most Extensive Catalog of Pseudotyped & Virus-like Particles


Explore Related Content

Pseudotyped and pseudoinfective particles for virology and vaccine discovery
Target cell lines, neutralizing antibodies, and control pseudoviral particles for your RVP research
Other offerings, including TiterSafe for HAI assays, neutralization assay services, and more

Featured Product Lines


“There are some hurdles to running live virus neutralization assays. RVPs made it easy to triage leads across many viral variants. The luciferase RVP assay was very easy to run, and it helped us identify mAbs with neutralizing activity against all the variants we tried.”

-CHUN-NAN CHEN, PHD, CEO & CSO, SINGLE CELL TECHNOLOGY

Case Studies: See how our customers have used RVPs

To see more case studies, plus publications and webinars, visit the Resources page


Reporter Virus Particles are available directly through our website or through our partner distributors.


Featured White Paper: Using Pseudoviruses in Neutralization Assays

Learn why virologists are increasingly turning to pseudoviruses as an alternative to live virus.

Download the white paper

Frequently Asked Questions

Contact Us